Tagraxofusp in Combination With Decitabine

Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1/2
Enrollment
64 patients (estimated)
Sponsors
MD Anderson Cancer Center
Tags
CD123
Trial Type
Treatment
Last Update
1 month ago
SparkCures ID
2116
NCT Identifier
NCT05038592

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.